- Growth Centre chaired by CEO of Standards Australia Dr Bronwyn Evans
- Established under Government’s Industry Growth Centres Initiative
- Positions Australia as hub for the medical technologies and pharmaceuticals sector in the Asia-Pacific region
Today marks the official launch of the Medical Technologies and Pharmaceuticals Growth Centre. This Growth Centre was established under the Government’s Industry Growth Centres Initiative, with a goal of increased innovation, competitiveness, and productivity for Australia.
Chair of the Growth Centre and CEO of Standards Australia, Dr Bronwyn Evans said, "Australia is already successfully participating in this sector's global value chains and this will position Australia even more strongly. Enabling digital technologies such as data analytics and cloud based application infrastructure will further enhance this capability."
As Chair, Dr Evans was responsible for the development of a long-term strategy within the Growth Centre’s Sector Competitiveness Plan. This strategy lays out an approach for boosting the capabilities of the medical technologies and pharmaceuticals sector, enabling stronger research-industry partnerships and opening up opportunities for international engagement.
Minister for Industry, Innovation and Science, Christopher Pyne, stated that “a key goal for this Growth Centre will be to forge better links between industry and Australia’s worldclass researchers, to maximise the return on our $9.7 billion annual investment in science and research.”
Based at the University of Sydney, the Growth Centre will be accessible nationwide with hubs located at major universities throughout the country.
To learn more about the Medical Technologies and Pharmaceuticals Growth Centre, visit www.business.gov.au/industrygrowthcentres
or read the media release
from the Department of Industry, Innovation and Science.